Skip to main content
. 2006 Nov 17;7(12):981–986. doi: 10.1631/jzus.2006.B0981

Table 2.

Comparison of various determinations between patients and controls

Group NO (nmol/L) LPO (µmol/L) SOD (U/g Hb) CAT (k/g Hb) GSH-Px (U/g Hb)
Patients (n=46) 467.6±8.8* 12.3±1.9* 20.9±4.0* 245.2±8.6* 24.8±3.0*
Controls (n=50) 327.7±86.4 10.1±1.6 26.0±7.6 321.2±37.7 31.8±3.8
*

P<0.001, compared with controls

Hb: Hemoglobin

HHS Vulnerability Disclosure